Rigel Pharmaceuticals | RIGL - Umsatzerlöse





Der Umsatz Veränderung Datum
Agenus USD 33.7M 500K 2026-03
Amgen USD 8.62B 1.28B 2026-03
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 73.74M 190.29M 2026-03
AstraZeneca USD 15.29B 213M 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Celldex Therapeutics USD 15K 106K 2026-03
Daiichi Sankyo JPY 587B 28.89B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Halozyme Therapeutics USD 377M 74.76M 2026-03
Heron Therapeutics USD 40.59M 2.38M 2025-12
Intrexon USD 717K 511K 2024-06
Ionis Pharmaceuticals USD 246M 43M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Ligand Pharmaceuticals USD 51.72M 7.94M 2026-03
MacroGenics USD 20.8M 20.43M 2026-03
Neurocrine Biosciences USD 811M 5.5M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Veracyte USD 139.07M 1.53M 2026-03